This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2002 by Control Delivery Systems.
Recruitment status was:  Active, not recruiting
Bausch & Lomb Incorporated
Information provided by:
Control Delivery Systems Identifier:
First received: March 20, 2002
Last updated: May 25, 2006
Last verified: December 2002
A study evaluating Retisert in patients with age-related macular degeneration

Condition Intervention Phase
Macular Degeneration Drug: Retisert Implant Phase 2

Study Type: Interventional
Study Design: Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Control Delivery Systems:

Study Start Date: November 2001

Ages Eligible for Study:   55 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00032396

United States, Massachusetts
Control Delivery Systems, Inc.
Watertown, Massachusetts, United States, 02472
Sponsors and Collaborators
Control Delivery Systems
Bausch & Lomb Incorporated
  More Information

Additional Information: Identifier: NCT00032396     History of Changes
Other Study ID Numbers: CDS FL-004
Study First Received: March 20, 2002
Last Updated: May 25, 2006

Keywords provided by Control Delivery Systems:
Age-Related Macular Degeneration
Subfoveal Choroidal Neovascularization

Additional relevant MeSH terms:
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases
Fluocinolone Acetonide
Anti-Inflammatory Agents
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs processed this record on August 18, 2017